Lutropin alfa

DRUG4 trials

Sponsors

Department Of Biomedical Metabolic And Neural Sciences, Royan Institute, Azienda Ospedaliero-Universitaria di Modena, CRG UZ Brussel

Conditions

Acquired Hypogonadotropic HypogonadismHypogonadotropic hypogonadismInfertilityPoor Response to Ovulation Induction

Phase 2

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men

RecruitingNCT04189133

Azienda Ospedaliero-Universitaria di ModenaAcquired Hypogonadotropic Hypogonadism

Start: 2022-01-19End: 2026-01-18Target: 32Updated: 2023-07-20

Pharmacodynamics and safety of human recombinant luteinising hormone in hypogonadotropic hypogonadal men

CompletedCTIS2024-518159-52-02

Department Of Biomedical Metabolic And Neural SciencesHypogonadotropic hypogonadism

End: 2025-04-04Target: 1Updated: 2025-01-27

Phase 4

Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism

Royan InstituteInfertility

Start: 2012-11-30End: 2016-11-30Target: 90Updated: 2015-05-06

Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

WithdrawnNCT05405686

CRG UZ BrusselPoor Response to Ovulation Induction

Start: 2023-05-01End: 2024-08-01Updated: 2024-02-28